Assessment of Efficacy and Safety of Tegaserod Treatment and Placebo in Women With Dyspepsia
Clinical trial NCT00232024 · COMPLETED
Trial details
- NCT number
- NCT00232024
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Enrollment
- 1296
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.